These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9058153)

  • 1. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
    Hino N; Higashi T; Nouso K; Nakatsukasa H; Urabe Y; Kinugasa N; Yoshida K; Ashida K; Ohguchi S; Tsuji T
    Hepatogastroenterology; 1997; 44(13):245-50. PubMed ID: 9058153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
    Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
    Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
    Horigome H; Nomura T; Saso K; Itoh M
    Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of c-kit and proliferating cell nuclear antigen in oval cells of rats with hepatocellular carcinoma.
    Fang CH; Zhang W; Zhu XY; Gong JQ; Zhang GQ
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):537-44. PubMed ID: 14627515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological study on early recurrent hepatoma and its treatment].
    Nakanishi K; Une Y; Saiki I; Haneda T; Okubo H; Tomioka N; Shimamura T; Kamiyama T; Matsushita M
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():269-72. PubMed ID: 9263514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma.
    Tanikawa K; Majima Y
    Hepatogastroenterology; 1993 Aug; 40(4):324-7. PubMed ID: 8406300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
    Saiki I; Une Y; Uchino J
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S; Saji S; Kuno T
    J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
    Donato MF; Arosio E; Del Ninno E; Ronchi G; Lampertico P; Morabito A; Balestrieri MR; Colombo M
    Hepatology; 2001 Sep; 34(3):523-8. PubMed ID: 11526538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence.
    Horigome H; Nomura T; Nakao H; Saso K; Takahashi Y; Akita S; Sobue S; Mizuno Y; Nojiri S; Hirose A; Masuko K; Murasaki G; Fujino N; Nakahara R; Ichikawa T; Itoh M
    Hepatogastroenterology; 2000; 47(32):507-11. PubMed ID: 10791223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
    Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
    Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
    Chapel F; Guettier C; Chastang C; Rached AA; Mathieu D; Tepper M; Beaugrand M; Trinchet JC
    Cancer; 1996 Mar; 77(5):864-71. PubMed ID: 8608476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
    Mun KS; Cheah PL; Baharudin NB; Looi LM
    Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C; Oshima CT; Lanzoni VP; Forones NM
    Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
    Ishii H; Okada S; Nose H; Okusaka T; Yoshimori M; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
    Cancer; 1996 May; 77(9):1792-6. PubMed ID: 8646676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.